Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.
Howes JM, Richardson VR, Smith KA, Schroeder V, Somani R, Shore A, Hess K, Ajjan R, Pease RJ, Keen JN, Standeven KF, Carter AM.
Howes JM, et al.
Diab Vasc Dis Res. 2012 Jul;9(3):216-25. doi: 10.1177/1479164111432788. Epub 2012 Jan 17.
Diab Vasc Dis Res. 2012.
PMID: 22253322
Free article.